The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.

While there are differences in each protocol, each trial aims to address different aspects of CRP in de novo HSPC. Therefore, the specific goals of each study and the limitations have to be taken into consideration when interpreting the results of these trials.